Clorox (CLX) Earns News Impact Score of 0.17

News stories about Clorox (NYSE:CLX) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Clorox earned a daily sentiment score of 0.17 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.0229568181276 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the news stories that may have effected Accern Sentiment Analysis’s rankings:

CLX has been the subject of a number of analyst reports. Jefferies Group reissued a “hold” rating and set a $132.00 price objective (down from $137.00) on shares of Clorox in a report on Friday, October 6th. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Morgan Stanley cut their price objective on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday, November 2nd. Consumer Edge raised Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Finally, Wells Fargo & Co lifted their price objective on Clorox from $130.00 to $146.00 and gave the company a “market perform” rating in a report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. Clorox has a consensus rating of “Hold” and a consensus price target of $134.33.

Clorox (NYSE CLX) traded up $0.72 during trading on Friday, hitting $143.86. The company had a trading volume of 789,749 shares, compared to its average volume of 751,037. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. Clorox has a fifty-two week low of $118.87 and a fifty-two week high of $150.40. The company has a market capitalization of $18,550.00, a PE ratio of 26.40, a price-to-earnings-growth ratio of 3.77 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.05. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The business had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the previous year, the business posted $1.36 earnings per share. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. equities analysts predict that Clorox will post 5.7 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.34%. Clorox’s dividend payout ratio is 61.65%.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of Clorox stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the transaction, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Week Herald and is owned by of Week Herald. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://weekherald.com/2018/01/19/clorox-clx-earns-news-impact-score-of-0-17.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Insider Buying and Selling by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply